Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study

• Asıl Yazarlar: Khaled Naja (Yazar), Najeha Anwardeen (Yazar), Sara S. Bashraheel (Yazar), Mohamed A. Elrayess (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundSulfonylureas have been a longstanding pharmacotherapy in the management of type 2 diabetes, with potential benefits beyond glycemic control. Although sulfonylureas are effective, interindividual variability exists in drug response. Pharmacometabolomics is a potent method for elucidating v...